Baudax Bio Email Format

Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees

Baudax Bio is a small specialty pharmaceutical company focused on developing and commercializing non-opioid therapies for acute care settings. Its lead product, ANJESO, is an injectable analgesic for adults to manage moderate-to-severe pain, used alone or with other non-NSAID analgesics. The company's pipeline includes early-stage candidates such as two novel neuromuscular blockers with a related reversal agent, and a proprietary intranasal formulation of dexmedetomidine known as Dex-IN, which has sedative as well as analgesic and anxiolytic properties.

Baudax Bio targets hospitals and related acute care environments as its primary customers, addressing pain management needs with non-opioid options and pursuing acquisitions and licensing aligned with its core focus. Based in Malvern, Pennsylvania, the company has pursued partnerships in 2023, including a collaboration with TeraImmune to support its development efforts.

Sign up for free to view info

Company overview Employee directory